Your browser doesn't support javascript.
loading
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji, Jiao; Yu, Yan; Li, Zhi-Ling; Chen, Ming-Yuan; Deng, Rong; Huang, Xiang; Wang, Guang-Feng; Zhang, Meng-Xia; Yang, Qi; Ravichandran, Senthilkumar; Feng, Gong-Kan; Xu, Xue-Lian; Yang, Chen-Lu; Qiu, Miao-Zhen; Jiao, Lin; Yang, Dajun; Zhu, Xiao-Feng.
Afiliação
  • Ji J; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yu Y; Ascentage Pharma Group Corp. Limited, Jiangsu, China.
  • Li ZL; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen MY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Deng R; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang GF; Department of Biochemistry, the School of Medicine, Jinan University, Guangzhou, China.
  • Zhang MX; Ascentage Pharma Group Corp. Limited, Jiangsu, China.
  • Yang Q; Department of Radiotherapy, Fujian Medical University Union Hospital, China.
  • Ravichandran S; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Feng GK; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu XL; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang CL; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Qiu MZ; Department of Gynecology, Women and children hospital of Guangdong Province, Guangzhou, China.
  • Jiao L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang D; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhu XF; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Theranostics ; 8(6): 1494-1510, 2018.
Article em En | MEDLINE | ID: mdl-29556337
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azepinas / Regulação Neoplásica da Expressão Gênica / Neoplasias Nasofaríngeas / Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X / Fatores de Transcrição SOXB1 / Carcinoma Nasofaríngeo Tipo de estudo: Prognostic_studies Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azepinas / Regulação Neoplásica da Expressão Gênica / Neoplasias Nasofaríngeas / Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X / Fatores de Transcrição SOXB1 / Carcinoma Nasofaríngeo Tipo de estudo: Prognostic_studies Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Austrália